AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Opera to make sense in a portfolio, you need to believe its browser, MiniPay ecosystem and AI products can keep pulling in more users and monetization, while management continues returning cash via dividends and buybacks. The latest Q2 numbers, with higher earnings per share from continuing operations, broadly support that thesis and align with earlier guidance, so they seem more like confirmation than a big reset of the story. Near term, the key catalysts still look tied to execution on MiniPay, the Visa-backed MiniPay Card rollout, and further AI adoption within its browsers, with these results giving Opera a bit more financial flexibility to keep investing. On the risk side, a relatively new management team, low board independence and reliance on a few high-growth initiatives remain important pressure points that Q2’s strength does not fully address.
However, one governance concern here is something investors should not overlook. Despite retreating, Opera's shares might still be trading above their fair value and there could be some more downside. Discover how much.Explore 7 other fair value estimates on Opera - why the stock might be worth just $23.00!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com